130 related articles for article (PubMed ID: 38871367)
1. MR Imaging Findings in Anti-Leucine-Rich Glioma Inactivated Protein 1 Encephalitis: A Systematic Review and Meta-analysis.
Almeida FC; Pereira AI; Mendes-Pinto C; Lopes J; Moura J; Sousa JM; Videira G; Samões R; Oliveira TG
AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38871367
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of 28 cases of anti
Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis.
Kelly MJ; Grant E; Murchison AG; Binks S; Ramanathan S; Michael S; Handel AE; Handunnetthi L; Uy CE; Soltys JN; Dubey D; Day GS; Lopez-Chiriboga AS; Flanagan EP; Sheerin F; Irani SR
JAMA Neurol; 2024 May; 81(5):525-533. PubMed ID: 38497971
[TBL] [Abstract][Full Text] [Related]
4. Brain Magnetic Resonance Imaging Characteristics of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis and Their Clinical Relevance: A Single-Center Study in China.
Shao X; Fan S; Luo H; Wong TY; Zhang W; Guan H; Qiu A
Front Neurol; 2020; 11():618109. PubMed ID: 33510707
[No Abstract] [Full Text] [Related]
5. Clinical features of nine cases of leucine-rich glioma inactivated 1 protein antibody-associated encephalitis.
Li Y; Song F; Liu W; Wang Y
Acta Neurol Belg; 2021 Aug; 121(4):889-897. PubMed ID: 32232701
[TBL] [Abstract][Full Text] [Related]
6. Anti-LGI1 encephalitis recurring 3 years after the first episode: a case report.
Fujita H; Shioda M; Suzuki K
BMC Neurol; 2022 Apr; 22(1):148. PubMed ID: 35448972
[TBL] [Abstract][Full Text] [Related]
7. Bi-Basal Ganglia Involvement with Signal Evolution in a Case of Anti-LGI1 Encephalitis.
Gai Q; Ruan S; Dong X; Cong S
Neurol India; 2022; 70(1):384-386. PubMed ID: 35263922
[TBL] [Abstract][Full Text] [Related]
8. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
9. Anti-leucine-rich glioma inactivated protein 1 encephalitis with sleep disturbance as the first symptom: A case report and review of literature.
Kong DL
World J Clin Cases; 2023 Jan; 11(2):408-416. PubMed ID: 36686352
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
11. Characterization of neuroinflammation pattern in anti-LGI1 encephalitis based on TSPO PET and symptom clustering analysis.
Wang J; Ge J; Jin L; Deng B; Tang W; Yu H; Zhang X; Liu X; Xue L; Zuo C; Chen X
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2394-2408. PubMed ID: 36929211
[TBL] [Abstract][Full Text] [Related]
12. Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review.
Roberto KT; Espiritu AI; Fernandez MLL; Gutierrez JC
Epilepsy Behav; 2020 Nov; 112():107462. PubMed ID: 32971385
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance and extra-hypothalamus dysfunction of hyponatremia in anti-leucine-rich glioma-inactivated protein 1 encephalitis.
Liu X; Li G; Yu T; Lv R; Cui T; Hogan RE; Wang Q
J Neuroimmunol; 2022 Dec; 373():578000. PubMed ID: 36410057
[TBL] [Abstract][Full Text] [Related]
14. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
Li Z; Cui T; Shi W; Wang Q
Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
[TBL] [Abstract][Full Text] [Related]
15. A Chinese female Morvan patient with LGI1 and CASPR2 antibodies: a case report.
Zhang L; Lu Q; Guan HZ; Mei JH; Ren HT; Liu MS; Peng B; Cui LY
BMC Neurol; 2016 Mar; 16():37. PubMed ID: 26983964
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric Manifestation of Anti-LGI1 Encephalitis.
Endres D; Prüss H; Dressing A; Schneider J; Feige B; Schweizer T; Venhoff N; Nickel K; Meixensberger S; Matysik M; Maier SJ; Domschke K; Urbach H; Meyer PT; Tebartz van Elst L
Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32560097
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.
Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T
JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017
[TBL] [Abstract][Full Text] [Related]
18. Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis.
Sadaghiani MS; Roman S; Diaz-Arias LA; Habis R; Venkatesan A; Probasco JC; Solnes LB
Neuroradiology; 2023 Aug; 65(8):1225-1238. PubMed ID: 37264220
[TBL] [Abstract][Full Text] [Related]
19. CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.
Li J; Li H; Wang Y; Zhao X; Wang S; Li L
Front Immunol; 2022; 13():1071219. PubMed ID: 36685530
[TBL] [Abstract][Full Text] [Related]
20. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
